Year |
Citation |
Score |
2024 |
Brady A, Sheneman KR, Pulsifer AR, Price SL, Garrison TM, Maddipati KR, Bodduluri SR, Pan J, Boyd NL, Zheng JJ, Rai SN, Hellmann J, Haribabu B, Uriarte SM, Lawrenz MB. Type 3 secretion system induced leukotriene B4 synthesis by leukocytes is actively inhibited by Yersinia pestis to evade early immune recognition. Plos Pathogens. 20: e1011280. PMID 38271464 DOI: 10.1371/journal.ppat.1011280 |
0.329 |
|
2020 |
Lei C, Mu J, Teng Y, He L, Xu F, Zhang X, Sundaram K, Kumar A, Sriwastva MK, Lawrenz MB, Zhang L, Yan J, Feng W, McClain CJ, Zhang X, et al. Lemon Exosome-like Nanoparticles-Manipulated Probiotics Protect Mice from Infection. Iscience. 23: 101571. PMID 33083738 DOI: 10.1016/J.Isci.2020.101571 |
0.341 |
|
2019 |
Pulsifer AR, Vashishta A, Reeves SA, Wolfe JK, Palace SG, Proulx MK, Goguen J, Bodduluri SR, Haribabu B, Uriarte SM, Lawrenz MB. Redundant and cooperative roles for Yop effectors in the inhibition of human neutrophil exocytic responses revealed by gain-of-function approach. Infection and Immunity. PMID 31871100 DOI: 10.1128/Iai.00909-19 |
0.383 |
|
2019 |
Pulsifer AR, VanCleave TT, Lawrenz MB. Intracellular Assays to Monitor Survival and Growth of Yersinia pestis Within Macrophages. Methods in Molecular Biology (Clifton, N.J.). 2010: 181-196. PMID 31177439 DOI: 10.1007/978-1-4939-9541-7_13 |
0.438 |
|
2019 |
Will WR, Brzovic P, Le Trong I, Stenkamp RE, Lawrenz MB, Karlinsey JE, Navarre WW, Main-Hester K, Miller VL, Libby SJ, Fang FC. The Evolution of SlyA/RovA Transcription Factors from Repressors to Countersilencers in . Mbio. 10. PMID 30837332 DOI: 10.1128/Mbio.00009-19 |
0.511 |
|
2018 |
Hegde B, Bodduluri SR, Satpathy SR, Alghsham RS, Jala VR, Uriarte SM, Chung DH, Lawrenz MB, Haribabu B. Inflammasome-Independent Leukotriene BProduction Drives Crystalline Silica-Induced Sterile Inflammation. Journal of Immunology (Baltimore, Md. : 1950). PMID 29610142 DOI: 10.4049/Jimmunol.1701504 |
0.303 |
|
2018 |
Connor MG, Pulsifer AR, Chung D, Rouchka EC, Ceresa BK, Lawrenz MB.
Targets the Host Endosome Recycling Pathway during the Biogenesis of the-Containing Vacuole To Avoid Killing by Macrophages. Mbio. 9. PMID 29463656 DOI: 10.1128/Mbio.01800-17 |
0.704 |
|
2017 |
VanCleave TT, Pulsifer AR, Connor MG, Warawa JM, Lawrenz MB. Impact of Gentamicin Concentration and Exposure Time on Intracellular Yersinia pestis. Frontiers in Cellular and Infection Microbiology. 7: 505. PMID 29312891 DOI: 10.3389/Fcimb.2017.00505 |
0.692 |
|
2017 |
Bobrov AG, Kirillina O, Fosso MY, Fetherston JD, Miller MC, VanCleave TT, Burlison JA, Arnold WK, Lawrenz MB, Garneau-Tsodikova S, Perry RD. Zinc transporters YbtX and ZnuABC are required for the virulence of Yersinia pestis in bubonic and pneumonic plague in mice. Metallomics : Integrated Biometal Science. PMID 28540946 DOI: 10.1039/C7Mt00126F |
0.356 |
|
2017 |
Price C, Merchant M, Jones S, Best A, Von Dwingelo J, Lawrenz MB, Alam N, Schueler-Furman O, Kwaik YA. Host FIH-Mediated Asparaginyl Hydroxylation of Translocated Legionella pneumophila Effectors. Frontiers in Cellular and Infection Microbiology. 7: 54. PMID 28321389 DOI: 10.3389/Fcimb.2017.00054 |
0.323 |
|
2017 |
Lawrenz MB, denDekker AE, Cramer DE, Gabbard JD, Lafoe KM, Pfeffer TL, Sotsky JB, Vanover CD, Ellis-Grosse EJ, Warawa JM. ZTI-01 Treatment Improves Survival of Animals Infected with Multidrug Resistant Pseudomonas aeruginosa Open Forum Infectious Diseases. 4: S474-S474. DOI: 10.1093/Ofid/Ofx163.1213 |
0.342 |
|
2016 |
Payne JN, Waghwani HK, Connor MG, Hamilton W, Tockstein S, Moolani H, Chavda F, Badwaik V, Lawrenz MB, Dakshinamurthy R. Novel Synthesis of Kanamycin Conjugated Gold Nanoparticles with Potent Antibacterial Activity. Frontiers in Microbiology. 7: 607. PMID 27330535 DOI: 10.3389/Fmicb.2016.00607 |
0.657 |
|
2015 |
Connor MG, Pulsifer AR, Price CT, Abu Kwaik Y, Lawrenz MB. Yersinia pestis Requires Host Rab1b for Survival in Macrophages. Plos Pathogens. 11: e1005241. PMID 26495854 DOI: 10.1371/Journal.Ppat.1005241 |
0.705 |
|
2015 |
Lawrenz MB, Biller AE, Cramer DE, Kraenzle JL, Sotsky JB, Vanover CD, Yoder-Himes DR, Pollard A, Warawa JM. Development and evaluation of murine lung-specific disease models for Pseudomonas aeruginosa applicable to therapeutic testing. Pathogens and Disease. 73. PMID 25857733 DOI: 10.1093/Femspd/Ftv025 |
0.343 |
|
2014 |
Warawa JM, Lawrenz MB. Bioluminescent imaging of bacteria during mouse infection. Methods in Molecular Biology (Clifton, N.J.). 1098: 169-81. PMID 24166377 DOI: 10.1007/978-1-62703-718-1_14 |
0.367 |
|
2013 |
Lawrenz MB, Pennington J, Miller VL. Acquisition of omptin reveals cryptic virulence function of autotransporter YapE in Yersinia pestis. Molecular Microbiology. 89: 276-87. PMID 23701256 DOI: 10.1111/Mmi.12273 |
0.529 |
|
2012 |
Sun Y, Connor MG, Pennington JM, Lawrenz MB. Development of bioluminescent bioreporters for in vitro and in vivo tracking of Yersinia pestis. Plos One. 7: e47123. PMID 23071730 DOI: 10.1371/Journal.Pone.0047123 |
0.68 |
|
2011 |
Lenz JD, Lawrenz MB, Cotter DG, Lane MC, Gonzalez RJ, Palacios M, Miller VL. Expression during host infection and localization of Yersinia pestis autotransporter proteins. Journal of Bacteriology. 193: 5936-49. PMID 21873491 DOI: 10.1128/Jb.05877-11 |
0.547 |
|
2011 |
Weening EH, Cathelyn JS, Kaufman G, Lawrenz MB, Price P, Goldman WE, Miller VL. The dependence of the Yersinia pestis capsule on pathogenesis is influenced by the mouse background. Infection and Immunity. 79: 644-52. PMID 21115720 DOI: 10.1128/Iai.00981-10 |
0.54 |
|
2010 |
Lawrenz MB. Model systems to study plague pathogenesis and develop new therapeutics. Frontiers in Microbiology. 1: 119. PMID 21687720 DOI: 10.3389/Fmicb.2010.00119 |
0.311 |
|
2009 |
Lawrenz MB, Lenz JD, Miller VL. A novel autotransporter adhesin is required for efficient colonization during bubonic plague. Infection and Immunity. 77: 317-26. PMID 18936182 DOI: 10.1128/Iai.01206-08 |
0.566 |
|
2008 |
Felek S, Lawrenz MB, Krukonis ES. The Yersinia pestis autotransporter YapC mediates host cell binding, autoaggregation and biofilm formation. Microbiology (Reading, England). 154: 1802-12. PMID 18524935 DOI: 10.1099/Mic.0.2007/010918-0 |
0.402 |
|
2007 |
Lawrenz MB, Miller VL. Comparative analysis of the regulation of rovA from the pathogenic yersiniae. Journal of Bacteriology. 189: 5963-75. PMID 17573476 DOI: 10.1128/Jb.00528-07 |
0.449 |
|
2004 |
Lawrenz MB, Wooten RM, Norris SJ. Effects of vlsE complementation on the infectivity of Borrelia burgdorferi lacking the linear plasmid lp28-1. Infection and Immunity. 72: 6577-85. PMID 15501789 DOI: 10.1128/Iai.72.11.6577-6585.2004 |
0.68 |
|
2004 |
Ellison DW, Lawrenz MB, Miller VL. Invasin and beyond: regulation of Yersinia virulence by RovA. Trends in Microbiology. 12: 296-300. PMID 15165608 DOI: 10.1016/J.Tim.2004.04.006 |
0.505 |
|
2003 |
Lawrenz MB, Wooten RM, Zachary JF, Drouin SM, Weis JJ, Wetsel RA, Norris SJ. Effect of complement component C3 deficiency on experimental Lyme borreliosis in mice. Infection and Immunity. 71: 4432-40. PMID 12874322 DOI: 10.1128/Iai.71.8.4432-4440.2003 |
0.562 |
|
2003 |
Purser JE, Lawrenz MB, Caimano MJ, Howell JK, Radolf JD, Norris SJ. A plasmid-encoded nicotinamidase (PncA) is essential for infectivity of Borrelia burgdorferi in a mammalian host. Molecular Microbiology. 48: 753-64. PMID 12694619 DOI: 10.1046/J.1365-2958.2003.03452.X |
0.691 |
|
2002 |
Lawrenz MB, Kawabata H, Purser JE, Norris SJ. Decreased electroporation efficiency in Borrelia burgdorferi containing linear plasmids lp25 and lp56: impact on transformation of infectious B. burgdorferi. Infection and Immunity. 70: 4798-804. PMID 12183522 DOI: 10.1128/Iai.70.9.4798-4804.2002 |
0.663 |
|
2002 |
Magnarelli LA, Lawrenz M, Norris SJ, Fikrig E. Comparative reactivity of human sera to recombinant VlsE and other Borrelia burgdorferi antigens in class-specific enzyme-linked immunosorbent assays for Lyme borreliosis. Journal of Medical Microbiology. 51: 649-55. PMID 12171295 DOI: 10.1099/0022-1317-51-8-649 |
0.531 |
|
2002 |
Eicken C, Sharma V, Klabunde T, Lawrenz MB, Hardham JM, Norris SJ, Sacchettini JC. Crystal structure of Lyme disease variable surface antigen VlsE of Borrelia burgdorferi. The Journal of Biological Chemistry. 277: 21691-6. PMID 11923306 DOI: 10.1074/Jbc.M201547200 |
0.485 |
|
1999 |
Lawrenz MB, Hardham JM, Owens RT, Nowakowski J, Steere AC, Wormser GP, Norris SJ. Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi. Journal of Clinical Microbiology. 37: 3997-4004. PMID 10565921 DOI: 10.1128/Jcm.37.12.3997-4004.1999 |
0.519 |
|
Show low-probability matches. |